CNTB logo

Connect Biopharma Holdings Limited (CNTB) EBIT

Annual EBIT

-$59.36 M
+$58.41 M+49.60%

31 December 2023

CNTB EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CNTB EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+49.6%--
3 y3 years+50.2%--
5 y5 years---

CNTB EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+70.6%
5 y5 years-146.4%+70.6%
alltimeall time-146.4%+70.6%

Connect Biopharma Holdings Limited EBIT History

DateAnnualQuarterlyTTM
Dec 2023
-$59.36 M(-49.6%)
-
-
Dec 2022
-$117.77 M(-41.7%)
-
-
DateAnnualQuarterlyTTM
Dec 2021
-$201.99 M(+69.4%)
-
-
Dec 2020
-$119.26 M(+395.0%)
-
-
Dec 2019
-$24.09 M
-
-

FAQ

  • What is Connect Biopharma Holdings Limited annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Connect Biopharma Holdings Limited?
  • What is Connect Biopharma Holdings Limited annual EBIT year-on-year change?

What is Connect Biopharma Holdings Limited annual earnings before interest & taxes?

The current annual EBIT of CNTB is -$59.36 M

What is the all time high annual EBIT for Connect Biopharma Holdings Limited?

Connect Biopharma Holdings Limited all-time high annual earnings before interest & taxes is -$23.98 M

What is Connect Biopharma Holdings Limited annual EBIT year-on-year change?

Over the past year, CNTB annual earnings before interest & taxes has changed by +$58.41 M (+49.60%)